︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎✦ 𝙒𝙚𝙡𝙘𝙤𝙢𝙚 𝙩𝙤 𝙩𝙝𝙚 𝙃𝙖𝙯𝙗𝙞𝙣 𝙃𝙤𝙩𝙚𝙡 ✦ ︎─────────────────── 𝘱𝘩𝘰𝘵𝘰 @_tsumi_ki 𝘈𝘭𝘢𝘴𝘵𝘰𝘳 @hgy_aaa_0201 𝘊𝘩𝘢𝘳𝘭𝘪𝘦 @mkdd_cos ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎ ︎

$DOCS Q4 EARNINGS HIGHLIGHTS 🔹 Revenue: $145.4M (Est $144.07M) 🟢; +5% YoY 🔹 Adj. EPS: $0.26 (Est $0.28) 🔴 🔹 Adj EBITDA: $65.8M 🔹 Adj EBITDA Margin: 45.3% 🔹 Free Cash Flow: $107.3M; +11% YoY FY 2027 Guide: 🔹 Revenue: $664M-$676M (Est $643.6M) 🟢 🔹 Adj EBITDA: $323M-$335M Q1 FY27 Guide: 🔹 Revenue: $151M-$152M 🔹 Adjusted EBITDA: $68.5M-$69.5M Other Metrics: 🔹 Active Prescribers Using Workflow Tools: 800K+ in Q4 🔹 Clinical AI Usage: Nearly half of active prescribers used it last quarter 🔹 AI Prompts Per User: Nearly doubled from January to April 🔹 Aledade Partnership: Clinical AI Suite integrated into Aledade Assist 🔹 AI Tools: Scribe ambient notetaking and Ask clinical AI assistant Commentary: 🔸 “We’re thrilled to announce that we reached a new engagement record of over 800,000 active prescribers using our workflow tools in Q4.” 🔸 “Nearly half of those providers used our clinical AI last quarter, while our prompts per user nearly doubled from January to April alone.” 🔸 “Our new partnerships with Aledade and Photon build on that momentum, bringing our Clinical AI Suite to thousands of independent practices and enabling seamless in-workflow prescribing for the first time.”